Related Experiment Video
Updated: Mar 3, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic Factors in Severe Chagasic Heart Failure
Sandra de Araújo Costa1, Salvador Rassi1, Elis Marra da Madeira Freitas1
1Universidade Federal de Goiás, Goiânia, GO, Brazil.
Prognostic factors for severe Chagasic heart failure are identified. Non-sustained ventricular tachycardia and indexed left atrial volume independently predict mortality, with only 11% survival over 7.5 years.
Area of Science:
- Cardiology
- Tropical Medicine
- Public Health
Background:
- Prognostic factors are crucial in heart failure management.
- Limited data exists on prognostic factors in severe Chagasic heart failure.
Purpose of the Study:
- Identify clinical and laboratory factors associated with prognosis in severe Chagasic heart failure.
- Determine the association of these factors with mortality and survival over a 7.5-year follow-up period.
Main Methods:
- Evaluated 60 patients with severe Chagasic heart failure.
- Assessed variables including age, blood pressure, ejection fraction, serum sodium, creatinine, 6-minute walk test, non-sustained ventricular tachycardia, QRS width, indexed left atrial volume, and functional class.
Main Results:
- 88.3% of patients died during the 7.5-year follow-up, with an overall survival probability of approximately 11%.
- Non-sustained ventricular tachycardia (HR = 2.11) and indexed left atrial volume ≥ 72 mL/m2 (HR = 3.51) were identified as independent predictors of mortality.
Conclusions:
- Non-sustained ventricular tachycardia and indexed left atrial volume > 72 mL/m2 are independent predictors of mortality in severe Chagasic heart failure.
- These findings highlight the poor prognosis, with a cumulative survival probability of only 11% over 7.5 years.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure III: Clinical Manifestations

